Fortitude Valley
Fortitude Valley
Fortitude Valley, Queensland, Australia7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TRPTI Metabolic and GLP-1 Pharmacodynamic Study | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Not yet recruiting | Phase 4 | 2026-09-30 | NCT07850466 | |
| A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection | Blood-Borne Infections, DNA Virus Infections, Digestive System Diseases, Hepadnaviridae infectious disease, Infections, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 1 | 2026-09-25 | NCT07024641 | |
| Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not applicable | 2026-09-24 | NCT04662905 | |
| Effects of Macanity on Urinary Health in Males With Lower Urinary Tract Symptoms | Lower Urinary Tract Symptoms, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Urological Manifestations | Not yet recruiting | Phase 2 | 2026-09-11 | NCT07816172 | |
| Supplementation Absorption Comparison | Healthy Volunteer | Recruiting | Phase 4 | 2026-09-10 | NCT07791797 | |
| A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060) | AIDS, Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Slow Virus Diseases, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Active, not recruiting | Phase 2 | 2025-10-16 | NCT06891066 | |
| Levagen+ Efficacy Study on Diabetic Peripheral Neuropathy | Diabetic Peripheral Neuropathy | Recruiting | Phase 2 | 2025-07-23 | NCT07028528 |